Abivax (ABVX) Research & Development (2024 - 2026)
Abivax (ABVX) recorded quarterly Research & Development of -$58.0 million in Q1 2026, down 116.02% quarter-over-quarter from $362.2 million in Q4 2025, and down 40.3% on a YoY basis from -$97.2 million in Q1 2025.
Abivax (ABVX) Research & Development (2024 - 2026) Analysis & Trends
Abivax's Research & Development history runs 3 years deep, the most recent figure standing at -$58.0 million for Q1 2026.
- In Q1 2026, Research & Development fell 40.3% year-over-year to -$58.0 million; the TTM figure through Mar 2026 stood at $195.6 million (up 28.78% YoY), while the FY2025 annual figure was $206.9 million, up 32.15% from the prior year.
- Research & Development was -$58.0 million for Q1 2026 at Abivax, down from $362.2 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $362.2 million in Q4 2025 to a low of -$64.8 million in Q3 2025.
- Historically, Research & Development has averaged $34.3 million across 3 years, with a median of -$41.3 million in 2025.
- Biggest YoY gain for Research & Development was 33.18% in 2025; the steepest drop was 40.52% in 2025.
- A 3-year view of Research & Development shows it stood at $271.9 million in 2024, then jumped by 33.18% to $362.2 million in 2025, then tumbled by 116.02% to -$58.0 million in 2026.
- The last three Research & Development figures came in at -$58.0 million (Q1 2026), $362.2 million (Q4 2025), and -$64.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 1.46 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -2.30 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -58.00 Mn |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58.00 Mn |
| Dec 31, 2025 | 362.16 Mn |
| Sep 30, 2025 | -64.78 Mn |
| Jun 30, 2025 | -43.74 Mn |
| Mar 31, 2025 | -41.34 Mn |
| Dec 31, 2024 | 271.92 Mn |
| Sep 30, 2024 | -47.54 Mn |
| Jun 30, 2024 | -31.13 Mn |
| Mar 31, 2024 | -38.83 Mn |